The Effects of Synbiotics on Dextran-Sodium-Sulfate-Induced Acute Colitis: The Impact of Chitosan Oligosaccharides on Endogenous/Exogenous Lactiplantibacillus plantarum
- 2023-06-02
- Foods 12(11)
- Yunjiao Zhao
- L. Xue
- Shunqin Li
- Tao Wu
- R. Liu
- Wenjie Sui
- M. Zhang
- PubMed: 37297494
- DOI: 10.3390/foods12112251
Abstract
In this work, Lactiplantibacillus plantarum (L. plantarum) isolated from mice feces (LP-M) and pickles (LP-P) were chosen as the endogenous and exogenous L. plantarum, respectively, which were separately combined with chitosan oligosaccharides (COS) to be synbiotics. The anti-inflammatory activity of LP-M, LP-P, COS, and the synbiotics was explored using dextran-sodium-sulfate (DSS)-induced acute colitis mice, as well as by comparing the synergistic effects of COS with LP-M or LP-P. The results revealed that L. plantarum, COS, and the synbiotics alleviated the symptoms of mice colitis and inhibited the changes in short-chain fatty acids (SCFAs), tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, IL-10, and myeloperoxidase (MPO) caused by DSS. In addition, the intervention of L. plantarum, COS, and the synbiotics increased the relative abundance of beneficial bacteria Muribaculaceae and Lactobacillus and suppressed the pathogenic bacteria Turicibacter and Escherichia-Shigella. There was no statistically difference between LP-M and the endogenous synbiotics on intestinal immunity and metabolism. However, the exogenous synbiotics improved SCFAs, inhibited the changes in cytokines and MPO activity, and restored the gut microbiota more effectively than exogenous L. plantarum LP-P. This indicated that the anti-inflammatory activity of exogenous LP-P can be increased by combining it with COS as a synbiotic.
Keywords: Lactiplantibacillus plantarum; chitosan oligosaccharides; colitis; cytokines; gut microbiota; short-chain fatty acids.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactiplantibacillus plantarum LP-1 | Increased Abundance of Muribaculaceae | Beneficial | Moderate |
Lactiplantibacillus plantarum LP-1 | Increased Fecal Lactobacilli | Beneficial | Large |
Lactiplantibacillus plantarum LP-1 | Inhibited Changes in Short-Chain Fatty Acids | Beneficial | Moderate |
Lactiplantibacillus plantarum LP-1 | Reduced Colitis Symptoms | Beneficial | Moderate |
Lactiplantibacillus plantarum LP-1 | Reduced Interleukin-10 Levels | Beneficial | Moderate |
Lactiplantibacillus plantarum LP-1 | Reduced Interleukin-1β Levels | Beneficial | Moderate |
Lactiplantibacillus plantarum LP-1 | Reduced Interleukin-6 Levels | Beneficial | Moderate |
Lactiplantibacillus plantarum LP-1 | Reduced Myeloperoxidase Activity | Beneficial | Moderate |
Lactiplantibacillus plantarum LP-1 | Reduced Relative Abundance of Escherichia-Shigella | Beneficial | Moderate |
Lactiplantibacillus plantarum LP-1 | Reduced Tumor Necrosis Factor-α (TNF-α) | Beneficial | Moderate |
Lactiplantibacillus plantarum LP-1 | Reduced Turicibacter Abundance | Beneficial | Moderate |
Lactiplantibacillus plantarum Lp-115 | Improved Abundance of Beneficial Bacteria | Beneficial | Moderate |
Lactiplantibacillus plantarum Lp-115 | Reduced Colitis Symptoms | Beneficial | Moderate |
Lactiplantibacillus plantarum Lp-115 | Reduced Pro-Inflammatory Cytokines | Beneficial | Moderate |
Lactiplantibacillus plantarum Lp-115 | Restored Gut Microbiota Composition | Beneficial | Moderate |